Knight Therapeutics Inc.
KHTRF
$5.32
$0.030.57%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.00M | -2.68M | 130.90K | 7.83M | 2.94M |
| Total Depreciation and Amortization | 39.86M | 39.06M | 35.98M | 36.83M | 38.09M |
| Total Amortization of Deferred Charges | 705.10K | 662.90K | 662.90K | 662.90K | 662.90K |
| Total Other Non-Cash Items | 11.46M | 4.22M | 575.50K | -5.30M | -855.90K |
| Change in Net Operating Assets | 1.57M | -15.63M | -15.43M | -33.53M | -14.00M |
| Cash from Operations | 49.59M | 25.62M | 21.92M | 6.49M | 26.84M |
| Capital Expenditure | -1.37M | -1.41M | -1.38M | -1.44M | -1.85M |
| Sale of Property, Plant, and Equipment | 20.90K | 92.30K | 92.30K | 94.50K | 116.60K |
| Cash Acquisitions | -79.57M | -79.57M | -77.25M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.78M | 41.93M | 49.06M | 53.66M | 13.60M |
| Cash from Investing | -55.14M | -38.95M | -29.48M | 52.32M | 11.86M |
| Total Debt Issued | 112.07M | 111.75M | 113.38M | 4.74M | 3.47M |
| Total Debt Repaid | -93.44M | -71.56M | -69.59M | -21.62M | -21.52M |
| Issuance of Common Stock | 736.00K | 743.00K | 1.07M | 1.04M | 1.00M |
| Repurchase of Common Stock | -6.35M | -8.50M | -10.98M | -12.21M | -8.87M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.60M | -7.57M | -7.05M | -7.29M | -7.63M |
| Cash from Financing | 4.20M | 18.19M | 19.60M | -25.43M | -24.30M |
| Foreign Exchange rate Adjustments | -2.08M | 135.80K | -500.80K | 1.49M | 1.17M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.43M | 5.00M | 11.54M | 34.88M | 15.57M |